CORCEPT THERAPEUTICS INC (CORT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 300M 600M 900M Q4 '17: 159.2M Q1 '18: 189.3M Q2 '18: 216M Q3 '18: 237.7M Q4 '18: 251.2M Q1 '19: 258.4M Q2 '19: 268.4M Q3 '19: 285.4M Q4 '19: 306.5M Q1 '20: 334.9M Q2 '20: 351.2M Q3 '20: 356M Q4 '20: 353.9M Q1 '21: 340.1M Q2 '21: 343.1M Q3 '21: 352.9M Q4 '21: 366M Q1 '22: 380.2M Q2 '22: 392M Q3 '22: 397.6M Q4 '22: 401.9M Q1 '23: 413.8M Q2 '23: 428.2M Q3 '23: 450M Q4 '23: 482.4M Q1 '24: 523.5M Q2 '24: 569.6M Q3 '24: 628.6M Q4 '24: 675M Q1 '25: 685.4M Q2 '25: 716.1M Q3 '25: 741.2M Q4 '25: 761.4M Q1 '26: 769.1M Q2 '26: 830.8M Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

0 150M 300M 450M Q1 '13: 4.9M Q2 '13: 6M Q3 '13: 7.5M Q4 '13: 10.2M Q1 '14: 12.7M Q2 '14: 16.5M Q3 '14: 21M Q4 '14: 25.7M Q1 '15: 31.2M Q2 '15: 37.1M Q3 '15: 43.1M Q4 '15: 48.9M Q1 '16: 54.8M Q2 '16: 62.6M Q3 '16: 70.6M Q4 '16: 79.3M Q1 '17: 90.6M Q2 '17: 106M Q3 '17: 126.8M Q4 '17: 155.6M Q1 '18: 185.2M Q2 '18: 211.6M Q3 '18: 232.9M Q4 '18: 246M Q1 '19: 253.1M Q2 '19: 262.9M Q3 '19: 279.8M Q4 '19: 301M Q1 '20: 328.8M Q2 '20: 345.2M Q3 '20: 350.3M Q4 '20: 348.3M Q4 '13 Q4 '14 Q4 '15 Q4 '16 Q4 '17 Q4 '18 Q4 '19 Q4 '20

Operating Income TTM

-50M 0 50M 100M 150M Q4 '10: -27.4M Q1 '11: -28.5M Q2 '11: -30.9M Q3 '11: -30.2M Q4 '11: -32.3M Q1 '12: -36.3M Q1 '13: -36.2M Q2 '13: -39.4M Q3 '13: -41.4M Q4 '13: -41.5M Q1 '14: -43.4M Q2 '14: -39.2M Q3 '14: -34.6M Q4 '14: -27.6M Q1 '15: -18.8M Q2 '15: -13.4M Q3 '15: -8.2M Q4 '15: -3.4M Q1 '16: 1.2M Q2 '16: 3.9M Q3 '16: 6.8M Q4 '16: 10.2M Q1 '17: 14.3M Q2 '17: 25.6M Q3 '17: 36.2M Q4 '17: 52.9M Q1 '18: 69.1M Q2 '18: 76.9M Q3 '18: 86.3M Q4 '18: 89.5M Q1 '19: 87.5M Q2 '19: 91.5M Q3 '19: 101.5M Q4 '19: 111.6M Q1 '20: 130.4M Q2 '20: 141M Q3 '20: 132.7M Q4 '20: 128.2M Q1 '21: 110.1M Q2 '21: 106.8M Q3 '21: 118.3M Q4 '21: 124.5M Q1 '22: 131.6M Q2 '22: 131.1M Q3 '22: 126.8M Q4 '22: 112.6M Q1 '23: 100.7M Q2 '23: 98.9M Q3 '23: 98.1M Q4 '23: 107.3M Q1 '24: 121.9M Q2 '24: 127.9M Q3 '24: 143.4M Q4 '24: 137M Q1 '25: 110.9M Q2 '25: 102M Q3 '25: 65.6M Q4 '25: 44.8M Q1 '26: -8.2M Q2 '26: 6.4M Q3 '11 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Net Income TTM

-60M 0 60M 120M 180M Q4 '10: -26M Q1 '11: -27M Q2 '11: -30.2M Q3 '11: -29.5M Q4 '11: -32.4M Q1 '12: -36.3M Q1 '13: -39.1M Q2 '13: -43.4M Q3 '13: -46M Q4 '13: -46M Q1 '14: -47.9M Q2 '14: -43.5M Q3 '14: -38.6M Q4 '14: -31.4M Q1 '15: -22.3M Q2 '15: -16.7M Q3 '15: -11.3M Q4 '15: -6.4M Q1 '16: -1.6M Q2 '16: 1.3M Q3 '16: 4.5M Q4 '16: 8.1M Q1 '17: 12.5M Q2 '17: 24.2M Q3 '17: 35.4M Q4 '17: 129.1M Q1 '18: 142.2M Q2 '18: 147.7M Q3 '18: 151.7M Q4 '18: 75.4M Q1 '19: 76.2M Q2 '19: 78.2M Q3 '19: 86.8M Q4 '19: 94.2M Q1 '20: 106M Q2 '20: 114.1M Q3 '20: 109.4M Q4 '20: 106M Q1 '21: 99.4M Q2 '21: 97.6M Q3 '21: 106.5M Q4 '21: 112.5M Q1 '22: 111.8M Q2 '22: 112.7M Q3 '22: 116.9M Q4 '22: 101.4M Q1 '23: 94.5M Q2 '23: 94.6M Q3 '23: 91.4M Q4 '23: 106.1M Q1 '24: 118M Q2 '24: 126M Q3 '24: 141.8M Q4 '24: 141.2M Q1 '25: 134M Q2 '25: 133.7M Q3 '25: 106.1M Q4 '25: 99.7M Q1 '26: 47.3M Q2 '26: 55.2M Q3 '11 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Cost of Revenue TTM

0 5M 10M 15M Q1 '13: 111K Q2 '13: 86K Q3 '13: 102K Q4 '13: 144K Q1 '14: 298K Q2 '14: 490K Q3 '14: 685K Q4 '14: 882K Q1 '15: 1M Q2 '15: 1.2M Q3 '15: 1.3M Q4 '15: 1.4M Q4 '17: 3.6M Q1 '18: 4.1M Q2 '18: 4.5M Q3 '18: 4.8M Q4 '18: 5.2M Q1 '19: 5.3M Q2 '19: 5.5M Q3 '19: 5.6M Q4 '19: 5.5M Q1 '20: 6.1M Q2 '20: 6M Q3 '20: 5.8M Q4 '20: 5.6M Q1 '21: 5M Q2 '21: 5.1M Q3 '21: 5.2M Q4 '21: 5.3M Q1 '22: 5.3M Q2 '22: 5.2M Q3 '22: 5.3M Q4 '22: 5.4M Q1 '23: 5.5M Q2 '23: 5.8M Q3 '23: 6.1M Q4 '23: 6.5M Q1 '24: 7.6M Q2 '24: 8.6M Q3 '24: 9.8M Q4 '24: 10.9M Q1 '25: 10.8M Q2 '25: 11.7M Q3 '25: 13.4M Q4 '25: 13M Q1 '26: 13.5M Q2 '26: 14.1M Q1 '14 Q3 '15 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Operating Cash Flow TTM

-70M 0 70M 140M 210M Q2 '11: -26.4M Q3 '11: -26.6M Q4 '11: -27.4M Q1 '12: -30.3M Q2 '12: -30.9M Q3 '12: -33.6M Q4 '12: -36M Q1 '13: -37.4M Q2 '13: -38.8M Q3 '13: -38.1M Q4 '13: -37.1M Q1 '14: -36.6M Q2 '14: -36.3M Q3 '14: -33.6M Q4 '14: -27.4M Q1 '15: -18.1M Q2 '15: -9.2M Q3 '15: -2.4M Q4 '15: 3.1M Q1 '16: 8.2M Q2 '16: 9.9M Q3 '16: 18M Q4 '16: 18.4M Q1 '17: 24.7M Q2 '17: 38.6M Q3 '17: 40.6M Q4 '17: 60.9M Q1 '18: 85.8M Q2 '18: 85.4M Q3 '18: 119M Q4 '18: 115.7M Q1 '19: 104.9M Q2 '19: 115.3M Q3 '19: 109.2M Q4 '19: 136.1M Q1 '20: 145.7M Q2 '20: 173.3M Q3 '20: 165.4M Q4 '20: 152M Q1 '21: 144.1M Q2 '21: 135.3M Q3 '21: 153.5M Q4 '21: 167.9M Q1 '22: 177.7M Q2 '22: 151.4M Q3 '22: 136.4M Q4 '22: 120.3M Q1 '23: 111M Q2 '23: 135.3M Q3 '23: 154.5M Q4 '23: 126.7M Q1 '24: 124.5M Q2 '24: 123.4M Q3 '24: 143.8M Q4 '24: 198.3M Q1 '25: 179.3M Q2 '25: 182.4M Q3 '25: 163.6M Q4 '25: 142M Q1 '26: 120.5M Q2 '26: 109.7M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow TTM

-70M 0 70M 140M 210M Q2 '12: -31M Q3 '12: -33.7M Q4 '12: -36.2M Q1 '13: -37.6M Q2 '13: -38.9M Q3 '13: -38.3M Q4 '13: -37.2M Q1 '14: -36.8M Q2 '14: -36.6M Q3 '14: -33.9M Q4 '14: -27.6M Q1 '15: -18.2M Q2 '15: -9.3M Q3 '15: -2.5M Q4 '15: 3.1M Q1 '16: 8.2M Q2 '16: 9.9M Q3 '16: 17.9M Q4 '16: 18.2M Q1 '17: 24.4M Q2 '17: 38.2M Q3 '17: 40.2M Q4 '17: 60.5M Q1 '18: 85.4M Q2 '18: 85.2M Q3 '18: 118.8M Q4 '18: 115.4M Q1 '19: 104.4M Q2 '19: 114.4M Q3 '19: 108.1M Q4 '19: 135M Q1 '20: 144.8M Q2 '20: 172.8M Q3 '20: 164.4M Q4 '20: 150.7M Q1 '21: 142.8M Q2 '21: 133.9M Q3 '21: 152.7M Q4 '21: 167.4M Q1 '22: 177.4M Q2 '22: 151.2M Q3 '22: 135.9M Q4 '22: 119.9M Q1 '23: 110.6M Q2 '23: 134.8M Q3 '23: 154.4M Q4 '23: 126.5M Q1 '24: 124.3M Q2 '24: 122.9M Q3 '24: 141.7M Q4 '24: 196.1M Q1 '25: 177M Q2 '25: 180.5M Q3 '25: 163.3M Q4 '25: 141.8M Q1 '26: 120.1M Q2 '26: 106.9M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 50M 100M 150M Q2 '15: 107.9M Q3 '15: 108.5M Q1 '16: 109.7M Q2 '16: 115.3M Q3 '16: 116.4M Q1 '17: 121.2M Q2 '17: 123M Q3 '17: 125.7M Q1 '18: 127.7M Q2 '18: 127.5M Q3 '18: 126.2M Q1 '19: 123.9M Q2 '19: 121.8M Q3 '19: 121.8M Q1 '20: 122.2M Q2 '20: 123.2M Q3 '20: 124.5M Q1 '21: 129.7M Q2 '21: 126.7M Q3 '21: 125.1M Q1 '22: 115M Q2 '22: 115.4M Q3 '22: 116.6M Q1 '23: 115.4M Q2 '23: 109.6M Q3 '23: 111.1M Q1 '24: 109.9M Q2 '24: 111.2M Q3 '24: 113.7M Q1 '25: 119.8M Q2 '25: 120.5M Q3 '25: 119.4M Q1 '26: 104.4M Q2 '26: 118.4M Q2 '16 Q1 '18 Q3 '19 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.50 0.00 0.50 1.00 1.50 Q4 '10: -0.38 Q1 '11: -0.38 Q2 '11: -0.40 Q3 '11: -0.38 Q4 '11: -0.40 Q1 '12: -0.44 Q1 '13: -0.40 Q2 '13: -0.43 Q3 '13: -0.46 Q4 '13: -0.46 Q1 '14: -0.48 Q2 '14: -0.43 Q3 '14: -0.38 Q4 '14: -0.31 Q1 '15: -0.22 Q2 '15: -0.17 Q3 '15: -0.12 Q4 '15: -0.07 Q1 '16: -0.02 Q2 '16: 0.01 Q3 '16: 0.04 Q4 '16: 0.07 Q1 '17: 0.11 Q2 '17: 0.20 Q3 '17: 0.29 Q4 '17: 1.02 Q1 '18: 1.12 Q2 '18: 1.16 Q3 '18: 1.19 Q4 '18: 0.60 Q1 '19: 0.61 Q2 '19: 0.64 Q3 '19: 0.72 Q4 '19: 0.78 Q1 '20: 0.88 Q2 '20: 0.94 Q3 '20: 0.89 Q4 '20: 0.85 Q1 '21: 0.78 Q2 '21: 0.76 Q3 '21: 0.83 Q4 '21: 0.89 Q1 '22: 0.91 Q2 '22: 0.94 Q3 '22: 1.00 Q4 '22: 0.88 Q1 '23: 0.82 Q2 '23: 0.83 Q3 '23: 0.81 Q4 '23: 0.95 Q1 '24: 1.06 Q2 '24: 1.13 Q3 '24: 1.26 Q4 '24: 1.23 Q1 '25: 1.15 Q2 '25: 1.12 Q3 '25: 0.87 Q4 '25: 0.82 Q1 '26: 0.35 Q2 '26: 0.42 Q3 '11 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.